Answers are grounded in this paper and cite their sources.
Although no prospective randomized trials have been performed to date to demonstrate the best clinical and oncological results of embolization, several retrospective studies using arterial embolization for patients with renal cell carcinoma have shown encouraging results. Arterial embolization should be used as a neoadjuvant therapy prior to surgical resection of renal cell carcinoma to reduce the tumor and minimize intraoperative bleeding. Arterial embolization can also be used for palliative purposes in kidney cancer in the treatment of pain and hematuria, which is not amenable to conservative treatment.
No takes yet. Share an insight, caveat, or question.
Головко et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: